Amgen announced the appointment of Michael V. Drake, M.D., to its Board of Directors, effective immediately.  Dr. Drake will also serve as a member of the Board's Corporate Responsibility and Compliance Committee and its Governance and Nominating Committee.  Following the appointment of Dr. Drake, the Board will be composed of 13 directors, 12 of whom are independent.

Dr. Drake is president of the University of California, a system of 10 campuses, five medical centers and three nationally affiliated labs that serves more than 280,000 students and employs 230,000 faculty and staff.

"Michael is an accomplished physician and leader who heads one of the largest, most diverse and well-respected academic institutions in the world," said Robert A. Bradway, chairman and chief executive officer of Amgen.  "He will add tremendous value to Amgen given his extensive medical, scientific and leadership experience as we continue to drive innovation to address serious illness."

Dr. Drake previously served as president of The Ohio State University (OSU) from 2014 to 2020, a period during which the university saw all-time highs in applications, graduation rates, industry-sponsored research and academic preparation and diversity of in-coming classes.  Prior to OSU, he served for nine years as chancellor of the University of California, Irvine and was UC Irvine's systemwide vice president for health affairs from 2000 to 2005.

Dr. Drake received his undergraduate degree from Stanford University and his medical doctorate from the University of California, San Francisco. 

Source: Amgen  

«« Empowering Citizens to Address Global Challenges

Opioid Overdose Deaths to Grow Exponentially »»

Latest Articles

Amgen ,Michael V. Drake, Board of Directors Amgen announced the appointment of Michael V. Drake, M.D., to its Board of Directors, effective immediately.